Expansion and tumour specific cytokine secretion of bryostatin-activated T-cells from cryopreserved axillary lymph nodes of breast cancer patients
- 31 October 1993
- journal article
- Published by Elsevier BV in Surgical Oncology
- Vol. 2 (5), 273-282
- https://doi.org/10.1016/s0960-7404(06)80002-2
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Adoptive transfer of bryostatin 1-activated T cells provides long-term protection from tumour metastasesSurgical Oncology, 1992
- Bryostatin 1 Activates T Cells That Have Antitumor ActivityJournal of Immunotherapy, 1992
- The Effect of Bryostatin 1 on Human Lymphocyte-Mediated CytotoxicityJournal of Immunotherapy, 1991
- Activation and in vitro expansion of tumor‐reactive T Lymphocytes from lymph nodes draining human primary breast cancersJournal of Surgical Oncology, 1991
- Activation and expansion of cytotoxic T lymphocytes from tumor-draining lymph nodesCancer Immunology, Immunotherapy, 1990
- The effect of prostaglandins and indomethacin on cytotoxic T-lymphocytes and their precursorsInternational Journal of Immunopharmacology, 1989
- Melanoma-Specific Cytotoxic T Cells Generated from Peripheral Blood LymphocytesAnnals of Surgery, 1989
- The glioblastoma‐derived T‐cell suppressor factor/transforming growth factor beta2 inhibits the generation of lymphokineactivated killer (LAK) cellsInternational Journal of Cancer, 1988
- A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 AloneNew England Journal of Medicine, 1987
- A New Approach to the Adoptive Immunotherapy of Cancer with Tumor-Infiltrating LymphocytesScience, 1986